Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial

Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G et al (2017) Global, Regional, and National Burden of Cardiovascular Diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 70(1):1–25

Article  PubMed  PubMed Central  Google Scholar 

Bonaca MP, Braunwald E, Sabatine MS (2015) Long-term use of Ticagrelor in patients with prior Myocardial Infarction. N Engl J Med 373(13):1274–1275

PubMed  Google Scholar 

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057

Article  CAS  PubMed  Google Scholar 

Van Giezen JJJ, Nilsson L, Berntsson P, Wissing B-M, Giordanetto F, Tomlinson W et al (2009) Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation. J Thromb Haemost 7(9):1556–1565

Bae JP, Dobesh PP, Klepser DG, Anderson JD, Zagar AJ, McCollam PL et al (2012) Adherence and dosing frequency of common medications for cardiovascular patients. Am J Manag Care 18(3):139–146

PubMed  Google Scholar 

Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC (2009) Effect of medication dosing frequency on adherence in chronic Diseases. Am J Manag Care 15(6):e22–33

PubMed  Google Scholar 

Huber CA, Meyer MR, Steffel J, Blozik E, Reich O, Rosemann T (2019) Post-myocardial infarction (MI) care: Medication Adherence for secondary Prevention after MI in a large real-world Population. Clin Ther 41(1):107–117

Article  PubMed  Google Scholar 

Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B et al (2013) Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 382(9906):1714–1722

Article  PubMed  Google Scholar 

Rasmussen JN, Chong A, Alter DA (2007) Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute Myocardial Infarction. JAMA 297(2):177–186

Article  CAS  PubMed  Google Scholar 

Bingham JM, Black M, Anderson EJ, Li Y, Toselli N, Fox S et al (2021) Impact of Telehealth interventions on Medication Adherence for patients with type 2 Diabetes, Hypertension, and/or dyslipidemia: a systematic review. Ann Pharmacother 55(5):637–649

Article  PubMed  Google Scholar 

Chan MY, Koh KWL, Poh S-C, Marchesseau S, Singh D, Han Y et al (2021) Remote Postdischarge treatment of patients with Acute Myocardial Infarction by Allied Health Care Practitioners vs Standard Care: the IMMACULATE Randomized Clinical Trial. JAMA Cardiol 6(7):830–835

Article  PubMed  Google Scholar 

Ho PM, Lambert-Kerzner A, Carey EP, Fahdi IE, Bryson CL, Melnyk SD et al (2014) Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial. JAMA Intern Med 174(2):186–193

Article  PubMed  Google Scholar 

Kubica A, Kasprzak M, Obonska K, Fabiszak T, Laskowska E, Navarese EP et al (2015) Discrepancies in assessment of adherence to antiplatelet treatment after Myocardial Infarction. Pharmacology 95(1–2):50–58

Article  CAS  PubMed  Google Scholar 

Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schömig A et al (2009) Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent Thrombosis. J Am Coll Cardiol 53(10):849–856

Article  CAS  PubMed  Google Scholar 

Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56(12):919–933

Article  CAS  PubMed  Google Scholar 

Ndrepepa G, Schuster T, Hadamitzky M, Byrne RA, Mehilli J, Neumann FJ et al (2012) Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery Disease undergoing percutaneous coronary intervention. Circulation 125(11):1424–1431

Article  PubMed  Google Scholar 

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al (2012) Third universal definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1581–1598

Article  PubMed  Google Scholar 

Chow CK, Klimis H, Thiagalingam A, Redfern J, Hillis GS, Brieger D et al (2022) Text messages to improve Medication Adherence and secondary Prevention after Acute Coronary Syndrome: the TEXTMEDS Randomized Clinical Trial. Circulation 145(19):1443–1455

Article  PubMed  Google Scholar 

Schwalm JD, Ivers NM, Natarajan MK, Taljaard M, Rao-Melacini P, Witteman HO et al (2015) Cluster randomized controlled trial of delayed Educational Reminders for Long-Term Medication Adherence in ST-Elevation Myocardial Infarction (DERLA-STEMI). Am Heart J 170(5):903–913

Article  PubMed  Google Scholar 

Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM (2012) Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. Am Heart J 163(4):657–665 e1

Article  PubMed  Google Scholar 

Parsons HM (1974) What happened at Hawthorne? New evidence suggests the Hawthorne effect resulted from operant reinforcement contingencies. Science 183(4128):922–932

Article  CAS  PubMed  Google Scholar 

Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

Article  CAS  PubMed  Google Scholar 

Marcum ZA, Sevick MA, Handler SM (2013) Medication nonadherence: a diagnosable and treatable medical condition. JAMA 309(20):2105–2106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arora S, Shemisa K, Vaduganathan M, Qamar A, Gupta A, Garg SK et al (2019) Premature Ticagrelor discontinuation in Secondary Prevention of Atherosclerotic CVD: JACC Review topic of the Week. J Am Coll Cardiol 73(19):2454–2464

Article  CAS  PubMed  Google Scholar 

Bonaca MP, Bhatt DL, Oude Ophuis T, Steg PG, Storey R, Cohen M et al (2016) Long-term tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: a secondary analysis of the PEGASUS-TIMI 54 Trial. JAMA Cardiol 1(4):425–432

Article  PubMed  Google Scholar 

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation 145(3):e4–e17

PubMed  Google Scholar 

Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Rev Esp Cardiol (Engl Ed) 74(6):544

PubMed  Google Scholar 

Pietrzykowski L, Michalski P, Kosobucka A, Kasprzak M, Fabiszak T, Stolarek W et al (2020) Medication adherence and its determinants in patients after Myocardial Infarction. Sci Rep 10(1):12028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT et al (2014) Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study. BMC Cardiovasc Disord 14:100

Article  PubMed  PubMed Central  Google Scholar 

Latry P, Martin-Latry K, Lafitte M, Peter C, Couffinhal T (2012) Dual antiplatelet therapy after Myocardial Infarction and percutaneous coronary intervention: analysis of patient adherence using a French health insurance reimbursement database. EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 7(12):1413–1419

Lauffenburger JC, Choudhry NK (2018) A call for a systems-thinking Approach to Medication Adherence: stop blaming the patient. JAMA Intern Med 178(7):950–951

Article  PubMed  Google Scholar 

Alexopoulos D, Galati A, Xanthopoulou I, Mavronasiou E, Kassimis G, Theodoropoulos KC et al (2012) Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. J Am Coll Cardiol 60(3):193–199

Article  CAS  PubMed  Google Scholar 

Alexopoulos D, Xanthopoulou I, Stavrou K, Hahalis G, Davlouros P (2013) Platelet reactivity measurements reveal patient noncompliance during ticagrelor maintenance therapy. Can J Cardiol 29(12):1743e13–1743e14

Article  Google Scholar 

Comments (0)

No login
gif